Characterization of T-cell responses against IκBα in cancer patients

The nuclear factor κ light chain enhancer of activated B cells (NFκB) is constitutively active in most cancers, controlling multiple cellular processes including proliferation, invasion and resistance to therapy. NFκB is primarily regulated through the association with inhibitory proteins that are k...

Descripción completa

Detalles Bibliográficos
Autores principales: Munir, Shamaila, Frøsig, Thomas Mørch, Hansen, Morten, Svane, Inge Marie, Andersen, Mads Hald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518501/
https://www.ncbi.nlm.nih.gov/pubmed/23243592
http://dx.doi.org/10.4161/onci.21625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518501/
https://www.ncbi.nlm.nih.gov/pubmed/23243592
http://dx.doi.org/10.4161/onci.21625

Ejemplares similares